Despite these beneficial metabolic effects, a clear worsening of atherosclerosis was established in this atherosclerosis‐prone mouse model, which appears to involve an alternative ceramide generation pathway (via sphingomyelin hydrolysis) regulated by Smpd3/nSMase2. This evidence concerns the gene SMPD3 and atherosclerosis.